Free Trial

Kenvue (KVUE) Stock Forecast & Price Target

Kenvue logo
$23.04 -0.33 (-1.43%)
As of 12:56 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Kenvue - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
8
Buy
5

Based on 14 Wall Street analysts who have issued ratings for Kenvue in the last 12 months, the stock has a consensus rating of "Hold." Out of the 14 analysts, 1 has given a sell rating, 8 have given a hold rating, and 5 have given a buy rating for KVUE.

Consensus Price Target

$23.85
3.52% Upside
According to the 14 analysts' twelve-month price targets for Kenvue, the average price target is $23.85. The highest price target for KVUE is $29.00, while the lowest price target for KVUE is $18.00. The average price target represents a forecasted upside of 3.52% from the current price of $23.04.
Get the Latest News and Ratings for KVUE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Kenvue and its competitors.

Sign Up

KVUE Analyst Ratings Over Time

TypeCurrent Forecast
3/25/24 to 3/25/25
1 Month Ago
2/24/24 to 2/23/25
3 Months Ago
12/26/23 to 12/25/24
1 Year Ago
3/26/23 to 3/25/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
3 Buy rating(s)
7 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
8 Hold rating(s)
7 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$23.85$23.00$22.64$25.42
Forecasted Upside3.52% Upside-1.31% Downside4.99% Upside23.05% Upside
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Remove Ads

KVUE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

KVUE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Kenvue Stock vs. The Competition

TypeKenvueConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.29
2.49
2.54
Consensus RatingHoldHoldModerate Buy
Predicted Upside2.02% Upside44.23% Upside16.92% Upside
News Sentiment Rating
Positive News

See Recent KVUE News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/24/2025Evercore ISI
2 of 5 stars
Javier Escalante
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageIn-Line$25.00+7.11%
3/5/2025Canaccord Genuity Group
1 of 5 stars
Susan Anderson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$24.00 ➝ $29.00+25.84%
2/24/2025Piper Sandler
2 of 5 stars
Korinne Wolfmeyer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$24.00 ➝ $27.00+15.85%
2/7/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Peter Grom
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$23.00 ➝ $21.00+4.50%
2/3/2025Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Modi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$24.00 ➝ $24.00+12.97%
1/17/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Lieberman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$23.00 ➝ $21.00-1.20%
1/15/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Filippo Falorni
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$25.00 ➝ $21.00+0.77%
12/12/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$25.00 ➝ $24.00+7.96%
10/22/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$24.00 ➝ $27.00+18.11%
10/11/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$24.00 ➝ $25.00+17.15%
9/24/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$27.00+17.29%
5/8/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$20.00 ➝ $21.00+3.09%
4/11/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageUnderperform$18.00-11.02%
4/3/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Andersen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform
3/1/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy ➝ Neutral$20.00+5.24%
9/6/2023Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold
7/25/2023Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy
5/30/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$28.00+6.46%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:56 PM ET.


Should I Buy Kenvue Stock? KVUE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, March 20, 2025. Please send any questions or comments about these Kenvue pros and cons to contact@marketbeat.com.

Kenvue
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Kenvue Inc.:

  • Kenvue Inc. has shown strong institutional interest, with 97.64% of its stock owned by hedge funds and other institutional investors, indicating confidence in the company's future performance.
  • The company recently reported earnings per share of $0.26, meeting analysts' expectations, which reflects stability and reliability in its financial performance.
  • As of the latest trading session, Kenvue Inc. stock is priced at $23.35, which is within its 52-week range of $17.67 to $24.46, suggesting potential for growth as it approaches its high.
  • Kenvue Inc. has a solid market capitalization of approximately $44.62 billion, which positions it well for future investments and growth opportunities.
  • The company has a return on equity of 20.97%, indicating effective management and profitability relative to shareholder equity, which is attractive to investors looking for strong returns.

Kenvue
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Kenvue Inc. for these reasons:

  • The price-to-earnings (P/E) ratio of 44.05 suggests that the stock may be overvalued compared to its earnings, which could deter value-focused investors.
  • Kenvue Inc. has a debt-to-equity ratio of 0.66, which, while manageable, indicates that the company is using a significant amount of debt to finance its operations, potentially increasing financial risk.
  • The company's net margin of 6.66% is relatively low, which may raise concerns about its profitability compared to competitors in the industry.
  • Recent stock performance has shown volatility, with significant trading volume fluctuations, which could indicate uncertainty among investors.
  • With a price-to-earnings growth (P/E/G) ratio of 2.62, the stock may not be seen as a growth investment, as this ratio suggests that the stock's price is high relative to its expected earnings growth.

KVUE Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Kenvue is $23.85, with a high forecast of $29.00 and a low forecast of $18.00.

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Kenvue in the last year. There is currently 1 sell rating, 8 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" KVUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KVUE, but not buy additional shares or sell existing shares.

According to analysts, Kenvue's stock has a predicted upside of 3.52% based on their 12-month stock forecasts.

Over the previous 90 days, Kenvue's stock had 1 upgrade by analysts.

Kenvue has been rated by research analysts at Barclays, Canaccord Genuity Group, Citigroup, Evercore ISI, Piper Sandler, Royal Bank of Canada, and UBS Group in the past 90 days.

Analysts like Kenvue less than other "consumer staples" companies. The consensus rating score for Kenvue is 2.29 while the average consensus rating score for "consumer staples" companies is 2.49. Learn more on how KVUE compares to other companies.


This page (NYSE:KVUE) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners